BRAND NAME:
Eflozin

GENERIC NAME:
Empagliflozin

THERAPEUTIC SEGMENT:
Diabetology

INDICATIONS:
Eflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus

BRIEF DESCRIPTION:
Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It lowers blood sugar by causing the kidneys to get rid of more glucose in the urine. Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke.

DOSAGE FORM:
Tablets
10mg, 25mg

PACK SIZE:
30’s